Hugh Wynne-Edwards

Consumer Services

Health Technology

Commercial Services

Profile

Hugh Wynne-Edwards served as Chairman of Welichem Biotech, Inc. He received a BS from Aberdeen University, an MA and a PhD from Queen's University.

Former positions of Hugh Wynne-Edwards

Companies	Position	End
Welichem Biotech, Inc. Welichem Biotech, Inc. Pharmaceuticals: MajorHealth Technology Welichem Biotech, Inc. operates as a drug discovery and early stage drug development company focusing on novel therapeutics for autoimmune, inflammatory diseases and cancers. The firm's focus has been on research and development of its novel anti-inflammatory drug candidate, WBI-1001 and its derivatives, and its anticancer drug candidate, WBI-2100 and its derivatives. The company was founded on November 1, 2004 and is headquartered in Burnaby, Canada.	Chairman	2008-04-07
BC Research, Inc. BC Research, Inc. Miscellaneous Commercial ServicesCommercial Services BC Research, Inc. provides clinical research services. Its services include custom research, engineering, plant services and process commercialization services. The company is headquartered in Vancouver, Canada.	Founder	-

See the detail of Hugh Wynne-Edwards's experience

Training of Hugh Wynne-Edwards

University of Aberdeen	Undergraduate Degree
Queen's University	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies